Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Market Gems:Stocks w/Strong Earnings and High Tech. Rank -- Ignore unavailable to you. Want to Upgrade?

To: techtome who wrote (25315)	2/18/1999 4:45:00 PM
From: kendall harmon	Respond to of 120523

TRL for tomorrow. Here are H and Q's comments Firm: Hambrecht & Quist Date: 2/18/99 Total Renal Care Holdings, Inc. (TRL) BUY $9.00 FY98 A: 1.22 FY99 E: - Rob Lunbeck rlunbeck@hamquist.com TRC: Stock Crushed on Disappointing Report; Cut Rating and Estimates Total Renal Care (TRC) reported 4Q98 revenue and recurring EPS of $339.2 mil. and $0.30, below our estimates of $345.6 mil. and $0.37, respectively. Excluding certain unusual expenses in the quarter, it appears TRC would have reported EPS of $0.35. TRC also reported a $12.3 mil. charge primarily related to acquired A/R. We have lowered our rating to BUY and expect to cut our 1999 EPS estimate to the $1.55 range. At $9 the stock appears very cheap.